Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism
Identifieur interne : 003546 ( Main/Exploration ); précédent : 003545; suivant : 003547Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism
Auteurs : Joong-Seok Kim [Corée du Sud] ; Phil-Hyu Lee [Corée du Sud] ; Kwang-Soo Lee [Corée du Sud] ; Jeong-Wook Park [Corée du Sud] ; Yeong-In Kim [Corée du Sud] ; Yong-An Chung [Corée du Sud] ; Sung-Hoon Kim [Corée du Sud] ; Seung-Hyun Kim [Corée du Sud] ; Juhan Kim [Corée du Sud] ; Yun-Young Choi [Corée du Sud] ; Hee-Tae Kim [Corée du Sud]Source :
- Movement Disorders [ 0885-3185 ] ; 2006-11.
English descriptors
- KwdEn :
- 3-Iodobenzylguanidine (diagnostic use), 3-Iodobenzylguanidine (pharmacokinetics), Aged, Aged, 80 and over, Case-Control Studies, Cerebrovascular Disorders (drug therapy), Cerebrovascular Disorders (metabolism), Cerebrovascular Disorders (radionuclide imaging), Female, Heart (physiopathology), Heart (radionuclide imaging), Humans, MIBG scintigraphy, Male, Middle Aged, Parkinson's disease, Parkinsonian Disorders (drug therapy), Parkinsonian Disorders (metabolism), Parkinsonian Disorders (radionuclide imaging), Radionuclide Imaging (methods), Radiopharmaceuticals (diagnostic use), Radiopharmaceuticals (pharmacokinetics), vascular Parkinsonism.
- MESH :
- chemical , diagnostic use : 3-Iodobenzylguanidine, Radiopharmaceuticals.
- chemical , pharmacokinetics : 3-Iodobenzylguanidine, Radiopharmaceuticals.
- drug therapy : Cerebrovascular Disorders, Parkinsonian Disorders.
- metabolism : Cerebrovascular Disorders, Parkinsonian Disorders.
- methods : Radionuclide Imaging.
- physiopathology : Heart.
- radionuclide imaging : Cerebrovascular Disorders, Heart, Parkinsonian Disorders.
- Aged, Aged, 80 and over, Case-Control Studies, Female, Humans, Male, Middle Aged.
Abstract
The purpose of our study was to prospectively evaluate cardiac [123I]metaiodobenzylguanidine (MIBG) uptake in patients with cerebrovascular disease (CVD) who develop clinical symptoms of vascular Parkinsonism (VP). A total of 19 consecutive patients who developed Parkinsonism during the course of their CVD were enrolled in the study; 16 age‐matched subjects, and 30 patients with Parkinson's disease (PD) were also evaluated with cardiac MIBG uptake. MIBG uptake was assessed using the ratio of the heart to the upper mediastinum (H/M) according to planar scintigraphic data. The mean H/M ratio was significantly higher in patients with VP than in those with PD (2.28 ± 0.41 vs. 1.27 ± 0.13; P < 0.001). MIBG uptake did not differ between VP and controls (2.46 ± 0.33; P > 0.05). Our findings suggest that myocardial postganglionic sympathetic dysfunction found in PD is absent in most patients with VP. MIBG single photon emission computed tomography imaging may be useful to help distinguish between PD and VP patients in clinical practice. © 2006 Movement Disorder Society
Url:
DOI: 10.1002/mds.21112
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002A09
- to stream Istex, to step Curation: 002A09
- to stream Istex, to step Checkpoint: 002007
- to stream PubMed, to step Corpus: 002A73
- to stream PubMed, to step Curation: 002A73
- to stream PubMed, to step Checkpoint: 002E35
- to stream Ncbi, to step Merge: 001866
- to stream Ncbi, to step Curation: 001866
- to stream Ncbi, to step Checkpoint: 001866
- to stream Main, to step Merge: 004861
- to stream Main, to step Curation: 003546
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism</title><author><name sortKey="Kim, Joong Eok" sort="Kim, Joong Eok" uniqKey="Kim J" first="Joong-Seok" last="Kim">Joong-Seok Kim</name></author><author><name sortKey="Lee, Phil Yu" sort="Lee, Phil Yu" uniqKey="Lee P" first="Phil-Hyu" last="Lee">Phil-Hyu Lee</name></author><author><name sortKey="Lee, Kwang Oo" sort="Lee, Kwang Oo" uniqKey="Lee K" first="Kwang-Soo" last="Lee">Kwang-Soo Lee</name></author><author><name sortKey="Park, Jeong Ook" sort="Park, Jeong Ook" uniqKey="Park J" first="Jeong-Wook" last="Park">Jeong-Wook Park</name></author><author><name sortKey="Kim, Yeong N" sort="Kim, Yeong N" uniqKey="Kim Y" first="Yeong-In" last="Kim">Yeong-In Kim</name></author><author><name sortKey="Chung, Yong N" sort="Chung, Yong N" uniqKey="Chung Y" first="Yong-An" last="Chung">Yong-An Chung</name></author><author><name sortKey="Kim, Sung Oon" sort="Kim, Sung Oon" uniqKey="Kim S" first="Sung-Hoon" last="Kim">Sung-Hoon Kim</name></author><author><name sortKey="Kim, Seung Yun" sort="Kim, Seung Yun" uniqKey="Kim S" first="Seung-Hyun" last="Kim">Seung-Hyun Kim</name></author><author><name sortKey="Kim, Juhan" sort="Kim, Juhan" uniqKey="Kim J" first="Juhan" last="Kim">Juhan Kim</name></author><author><name sortKey="Choi, Yun Oung" sort="Choi, Yun Oung" uniqKey="Choi Y" first="Yun-Young" last="Choi">Yun-Young Choi</name></author><author><name sortKey="Kim, Hee Ae" sort="Kim, Hee Ae" uniqKey="Kim H" first="Hee-Tae" last="Kim">Hee-Tae Kim</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:27ED9BC5C7E4E6F9E407ADEEA30E0CFCBF73DD19</idno><date when="2006" year="2006">2006</date><idno type="doi">10.1002/mds.21112</idno><idno type="url">https://api.istex.fr/document/27ED9BC5C7E4E6F9E407ADEEA30E0CFCBF73DD19/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">002A09</idno><idno type="wicri:Area/Istex/Curation">002A09</idno><idno type="wicri:Area/Istex/Checkpoint">002007</idno><idno type="wicri:doubleKey">0885-3185:2006:Kim J:cardiac:i:metaiodobenzylguanidine</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:16991157</idno><idno type="wicri:Area/PubMed/Corpus">002A73</idno><idno type="wicri:Area/PubMed/Curation">002A73</idno><idno type="wicri:Area/PubMed/Checkpoint">002E35</idno><idno type="wicri:Area/Ncbi/Merge">001866</idno><idno type="wicri:Area/Ncbi/Curation">001866</idno><idno type="wicri:Area/Ncbi/Checkpoint">001866</idno><idno type="wicri:doubleKey">0885-3185:2006:Kim J:cardiac:i:metaiodobenzylguanidine</idno><idno type="wicri:Area/Main/Merge">004861</idno><idno type="wicri:Area/Main/Curation">003546</idno><idno type="wicri:Area/Main/Exploration">003546</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism</title><author><name sortKey="Kim, Joong Eok" sort="Kim, Joong Eok" uniqKey="Kim J" first="Joong-Seok" last="Kim">Joong-Seok Kim</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Neurology, The Catholic University of Korea, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Lee, Phil Yu" sort="Lee, Phil Yu" uniqKey="Lee P" first="Phil-Hyu" last="Lee">Phil-Hyu Lee</name><affiliation wicri:level="1"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Neurology, Ajou University Medical College, Suwon</wicri:regionArea><wicri:noRegion>Suwon</wicri:noRegion></affiliation></author><author><name sortKey="Lee, Kwang Oo" sort="Lee, Kwang Oo" uniqKey="Lee K" first="Kwang-Soo" last="Lee">Kwang-Soo Lee</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Neurology, The Catholic University of Korea, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Park, Jeong Ook" sort="Park, Jeong Ook" uniqKey="Park J" first="Jeong-Wook" last="Park">Jeong-Wook Park</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Neurology, The Catholic University of Korea, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Kim, Yeong N" sort="Kim, Yeong N" uniqKey="Kim Y" first="Yeong-In" last="Kim">Yeong-In Kim</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Neurology, The Catholic University of Korea, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Chung, Yong N" sort="Chung, Yong N" uniqKey="Chung Y" first="Yong-An" last="Chung">Yong-An Chung</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Nuclear Medicine, The Catholic University of Korea, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Kim, Sung Oon" sort="Kim, Sung Oon" uniqKey="Kim S" first="Sung-Hoon" last="Kim">Sung-Hoon Kim</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Nuclear Medicine, The Catholic University of Korea, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Kim, Seung Yun" sort="Kim, Seung Yun" uniqKey="Kim S" first="Seung-Hyun" last="Kim">Seung-Hyun Kim</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Neurology, Hanyang University Medical College, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Kim, Juhan" sort="Kim, Juhan" uniqKey="Kim J" first="Juhan" last="Kim">Juhan Kim</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Neurology, Hanyang University Medical College, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Choi, Yun Oung" sort="Choi, Yun Oung" uniqKey="Choi Y" first="Yun-Young" last="Choi">Yun-Young Choi</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Nuclear Medicine, Hanyang University Medical College, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author><author><name sortKey="Kim, Hee Ae" sort="Kim, Hee Ae" uniqKey="Kim H" first="Hee-Tae" last="Kim">Hee-Tae Kim</name><affiliation wicri:level="3"><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>Department of Neurology, Hanyang University Medical College, Seoul</wicri:regionArea><placeName><settlement type="city">Séoul</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2006-11">2006-11</date><biblScope unit="vol">21</biblScope><biblScope unit="issue">11</biblScope><biblScope unit="page" from="1990">1990</biblScope><biblScope unit="page" to="1994">1994</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">27ED9BC5C7E4E6F9E407ADEEA30E0CFCBF73DD19</idno><idno type="DOI">10.1002/mds.21112</idno><idno type="ArticleID">MDS21112</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>3-Iodobenzylguanidine (diagnostic use)</term><term>3-Iodobenzylguanidine (pharmacokinetics)</term><term>Aged</term><term>Aged, 80 and over</term><term>Case-Control Studies</term><term>Cerebrovascular Disorders (drug therapy)</term><term>Cerebrovascular Disorders (metabolism)</term><term>Cerebrovascular Disorders (radionuclide imaging)</term><term>Female</term><term>Heart (physiopathology)</term><term>Heart (radionuclide imaging)</term><term>Humans</term><term>MIBG scintigraphy</term><term>Male</term><term>Middle Aged</term><term>Parkinson's disease</term><term>Parkinsonian Disorders (drug therapy)</term><term>Parkinsonian Disorders (metabolism)</term><term>Parkinsonian Disorders (radionuclide imaging)</term><term>Radionuclide Imaging (methods)</term><term>Radiopharmaceuticals (diagnostic use)</term><term>Radiopharmaceuticals (pharmacokinetics)</term><term>vascular Parkinsonism</term></keywords><keywords scheme="MESH" type="chemical" qualifier="diagnostic use" xml:lang="en"><term>3-Iodobenzylguanidine</term><term>Radiopharmaceuticals</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>3-Iodobenzylguanidine</term><term>Radiopharmaceuticals</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Cerebrovascular Disorders</term><term>Parkinsonian Disorders</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Cerebrovascular Disorders</term><term>Parkinsonian Disorders</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Radionuclide Imaging</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Heart</term></keywords><keywords scheme="MESH" qualifier="radionuclide imaging" xml:lang="en"><term>Cerebrovascular Disorders</term><term>Heart</term><term>Parkinsonian Disorders</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Case-Control Studies</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The purpose of our study was to prospectively evaluate cardiac [123I]metaiodobenzylguanidine (MIBG) uptake in patients with cerebrovascular disease (CVD) who develop clinical symptoms of vascular Parkinsonism (VP). A total of 19 consecutive patients who developed Parkinsonism during the course of their CVD were enrolled in the study; 16 age‐matched subjects, and 30 patients with Parkinson's disease (PD) were also evaluated with cardiac MIBG uptake. MIBG uptake was assessed using the ratio of the heart to the upper mediastinum (H/M) according to planar scintigraphic data. The mean H/M ratio was significantly higher in patients with VP than in those with PD (2.28 ± 0.41 vs. 1.27 ± 0.13; P < 0.001). MIBG uptake did not differ between VP and controls (2.46 ± 0.33; P > 0.05). Our findings suggest that myocardial postganglionic sympathetic dysfunction found in PD is absent in most patients with VP. MIBG single photon emission computed tomography imaging may be useful to help distinguish between PD and VP patients in clinical practice. © 2006 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Corée du Sud</li></country><settlement><li>Séoul</li></settlement></list><tree><country name="Corée du Sud"><noRegion><name sortKey="Kim, Joong Eok" sort="Kim, Joong Eok" uniqKey="Kim J" first="Joong-Seok" last="Kim">Joong-Seok Kim</name></noRegion><name sortKey="Choi, Yun Oung" sort="Choi, Yun Oung" uniqKey="Choi Y" first="Yun-Young" last="Choi">Yun-Young Choi</name><name sortKey="Chung, Yong N" sort="Chung, Yong N" uniqKey="Chung Y" first="Yong-An" last="Chung">Yong-An Chung</name><name sortKey="Kim, Hee Ae" sort="Kim, Hee Ae" uniqKey="Kim H" first="Hee-Tae" last="Kim">Hee-Tae Kim</name><name sortKey="Kim, Juhan" sort="Kim, Juhan" uniqKey="Kim J" first="Juhan" last="Kim">Juhan Kim</name><name sortKey="Kim, Seung Yun" sort="Kim, Seung Yun" uniqKey="Kim S" first="Seung-Hyun" last="Kim">Seung-Hyun Kim</name><name sortKey="Kim, Sung Oon" sort="Kim, Sung Oon" uniqKey="Kim S" first="Sung-Hoon" last="Kim">Sung-Hoon Kim</name><name sortKey="Kim, Yeong N" sort="Kim, Yeong N" uniqKey="Kim Y" first="Yeong-In" last="Kim">Yeong-In Kim</name><name sortKey="Lee, Kwang Oo" sort="Lee, Kwang Oo" uniqKey="Lee K" first="Kwang-Soo" last="Lee">Kwang-Soo Lee</name><name sortKey="Lee, Phil Yu" sort="Lee, Phil Yu" uniqKey="Lee P" first="Phil-Hyu" last="Lee">Phil-Hyu Lee</name><name sortKey="Park, Jeong Ook" sort="Park, Jeong Ook" uniqKey="Park J" first="Jeong-Wook" last="Park">Jeong-Wook Park</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003546 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003546 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:27ED9BC5C7E4E6F9E407ADEEA30E0CFCBF73DD19
|texte= Cardiac [123I]metaiodobenzylguanidine scintigraphy for vascular Parkinsonism
}}
| This area was generated with Dilib version V0.6.23. |  |